Akademik Veri Yönetim Sistemi
BREASTANBUL CONFERENCE 2024, İstanbul, Türkiye, 10 - 12 Ekim 2024, cilt.1, sa.1, ss.128, (Özet Bildiri)
Objective: Breast cancer is the leading cause of cancer related death among woman around the world. With 2.2 million new cases and 600.000
deaths annually, it is one of the biggest public health problems among woman as well. New advances on both the diagnosing and treating
breast cancer led to an almost %90 of 5-year survival rate on wealthy countries. Even though these advances prolong the lives of patients, they
come with a symptom burden which lowers the patient’s quality of life. Sexuality is one of the more important factors of quality of life among
breast cancer patients. Almost every breast cancer patient (%93) experiences some sort of sexual symptom, despite this significance sexual
symptoms remains one of the more undertreated side effects of breast cancer treatment. This study carried out a structured and comprehensive
systematic review of literature to identify the nature of these sexual symptoms.
Materials-Methods: The search was conducted in Google Scholar, PUBMED, Web of Science and CINAHL. “Breast cancer”, “sexual symptoms”,
“hormone therapy”, “endocrine therapy” and “symptom burden” keywords were used. Articles published between years 2014-2024 and written
in Turkish or English were included in this systematic review.
Results: Total of 2,287 articles were found at the initial search and after the investigation of these articles a total of 13 of articles were included
in the systematic review. Most common reasons that are associated with sexual symptoms were body image disruptions, lower physical activity,
fatigue and sleep problems.
Conclusion: Results of this systematic review show significant results, nevertheless more research with higher quality regarding the sexual
problems of breast cancer patients receiving adjuvant endocrine therapy should be conducted.
Keywords: Breast cancer, sexual symptoms, hormone therapy, endocrine therapy, symptom burden